Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1Phase 2 1

Status

Active not recruiting 3

Sponsor Class

OTHER 35INDUSTRY 32NIH 13NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Lymphoma, Mantle-Cell 2Lymphoma, B-Cell 1

Interventions

Specimen Handling 38Magnetic Resonance Spectroscopy 33Biopsy 16Radiation 15Cyclophosphamide 15Radiotherapy 14Vincristine 12Leucovorin 11Dexamethasone 11Carboplatin 11Etoposide 10Cisplatin 10Cytarabine 9Calcium Dobesilate 9dexamethasone acetate 8dexamethasone 21-phosphate 8auricularum 8Fluorouracil 8X-Rays 7Standard of Care 7Radiotherapy, Intensity-Modulated 7Practice Guidelines as Topic 7Platinum 7Doxorubicin 71,2-diaminocyclohexaneplatinum II citrate 7merphos 6dehydroftorafur 6Taxes 6Methotrexate 6Irinotecan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Rituximab × 30 days × Clear all
NCT04161248 2026-05-12

Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma

Canadian Cancer Trials Group

Phase EARLY_PHASE1 Active not recruiting
40 enrolled
Lymphoid

Lymphoma, B-Cell

NCT03267433 2026-05-05

Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
689 enrolled
Lymphoid

Lymphoma, Mantle-Cell

NCT04115631 2026-05-05

A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma

Eastern Cooperative Oncology Group

Phase 2 Active not recruiting
360 enrolled
Lymphoid

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡